Back to trial details

Intake questionnaire

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Applying to Emory University School of Medicine · Atlanta, Georgia

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you between 18 and 75 years old?
2. Have you been diagnosed with Amyloidosis?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Atlanta for study visits?